Sep 21, 2022
Aditxt Inc. (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, has closed on its recent public offering. The offering was comprised of 3,333,333 shares of common stock or common stock equivalents; the offering also included warrants to purchase up to 3,333,333 shares of common stock. The combined offering price to the public was $6 per share and associated warrant, with the warrants, which are exercisable upon being issued, having an exercise price of $6 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering, which resulted in approximately $20 million in gross proceeds for the company. Aditxt anticipates using the net proceeds from the offering for working capital and operating expenses.
To view the full press release, visit https://ibn.fm/1D16l
About Aditxt Inc.
Aditxt is a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system. The company’s immune monitoring technologies are designed to provide a personalized immune profile. Aditxt’s immune modulating technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies. For more information, please visit www.Aditxt.com and www.AditxtScore.com.
NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
Every look you need to see from the MTV Video Music Awards red carpet.
Square-shaped SUVs have proliferated across the lineups of Chinese auto brands, and Chery's design chief says the trend is here to stay.
Being a grandparent comes with many joys, including a lower risk of dementia.
Hanoi is the city of flavours, threaded with influences from Vietnam’s many regions, as well as China and the colonising French – so what to eat, and where?
Everyone’s packing digicams again. Before you buy one, learn the tricks to taking better snaps with the gadget in your hand.
With its easy wayfinding, central location and glass-roofed design, the third-busiest station in Great Britain is one of London’s most charming.
Australians can freely stay in Europe for up to 90 days, but there is a trap in the new entry system that travellers need to know about.
The four-cylinder Ford Everest diesel has lost a turbocharger, but it hasn't entirely lost its appeal.
Top up your inspiration bank with these dream kitchens as we share some of our favourite entries in this year’s awards
Those looking to get into an EV for the least money possible could have another option in the not-too-distant future with the Leapmotor B03 receiving local certification.
Mitsubishi is set to lean further on the heritage of its most famous SUV nameplate. We imagine what a Pajero Cross could look like.
The famed Italian performance car brand admits some customers still want a manual, but says its priority is evolving its new hybrid supercar formula.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.